Trial intelligence / Profile preview

Effect of zinc sulfate in human papillomavirus-related cervical cytology abnormalities

IRCT20210407050882N1Phase 2Completed

Sponsor
Urmia University of Medical Sciences
Start
Apr 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of zinc in human papillomavirus infection, sponsored by Urmia University of Medical Sciences. Started Apr 2021; status: completed.

02

Drugs

zinc
03

Conditions

human papillomavirus infection

Beyond the preview

Go deeper on IRCT20210407050882N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210407050882N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call